Mettler-Toledo [MTD] vs Thermo Fisher [TMO] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Mettler-Toledo International Inc. wins in 7 metrics, Thermo Fisher Scientific Inc. wins in 12 metrics, with 0 ties. Thermo Fisher Scientific Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Mettler-Toledo International Inc. | Thermo Fisher Scientific Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.07 | 25.84 | Thermo Fisher Scientific Inc. |
| Price-to-Book Ratio | -1,090.80 | 3.31 | Thermo Fisher Scientific Inc. |
| Debt-to-Equity Ratio | -95.84 | 82.91 | Thermo Fisher Scientific Inc. |
| PEG Ratio | 1.79 | 2.29 | Mettler-Toledo International Inc. |
| EV/EBITDA | 23.02 | 19.02 | Thermo Fisher Scientific Inc. |
| Profit Margin (TTM) | 21.59% | 15.15% | Mettler-Toledo International Inc. |
| Operating Margin (TTM) | 30.71% | 17.89% | Mettler-Toledo International Inc. |
| EBITDA Margin (TTM) | 30.71% | 17.89% | Mettler-Toledo International Inc. |
| Return on Equity | -3,677.41% | 13.52% | Thermo Fisher Scientific Inc. |
| Return on Assets (TTM) | 20.35% | 5.00% | Mettler-Toledo International Inc. |
| Free Cash Flow (TTM) | $848.65M | $6.29B | Thermo Fisher Scientific Inc. |
| Dividend Yield | N/A | 0.38% | N/A |
| 1-Year Return | 2.17% | 22.27% | Thermo Fisher Scientific Inc. |
| Price-to-Sales Ratio (TTM) | 6.36 | 3.86 | Thermo Fisher Scientific Inc. |
| Enterprise Value | $27.90B | $214.76B | Thermo Fisher Scientific Inc. |
| EV/Revenue Ratio | 6.93 | 4.75 | Thermo Fisher Scientific Inc. |
| Gross Profit Margin (TTM) | 59.79% | N/A | N/A |
| Revenue per Share (TTM) | $195 | $120 | Mettler-Toledo International Inc. |
| Earnings per Share (Diluted) | $42.05 | $18.18 | Mettler-Toledo International Inc. |
| Beta (Stock Volatility) | 1.44 | 0.97 | Thermo Fisher Scientific Inc. |
| Short % of Float | 3.44% | 1.22% | Thermo Fisher Scientific Inc. |
Mettler-Toledo International Inc. vs Thermo Fisher Scientific Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mettler-Toledo International Inc. | 0.95% | 1.46% | -6.35% | -8.25% | -17.03% | -16.36% |
| Thermo Fisher Scientific Inc. | 1.70% | -1.07% | 4.20% | -5.98% | -16.20% | -18.65% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mettler-Toledo International Inc. | 2.17% | -11.41% | -6.07% | 215.58% | 642.64% | 1,746.10% |
| Thermo Fisher Scientific Inc. | 22.27% | -5.31% | 9.75% | 222.18% | 684.25% | 1,233.99% |
Performance & Financial Health Analysis: Mettler-Toledo International Inc. vs Thermo Fisher Scientific Inc.
| Metric | MTD | TMO |
|---|---|---|
| Market Information | ||
| Market Cap | $25.60B | $174.55B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 135,040 | 2,356,220 |
| 90 Day Avg. Volume | 153,497 | 2,071,517 |
| Last Close | $1,180.48 | $482.03 |
| 52 Week Range | $1,023.05 - $1,525.17 | $385.46 - $643.99 |
| % from 52W High | -22.60% | -25.15% |
| All-Time High | $1,714.75 (Dec 27, 2021) | $672.34 (Dec 27, 2021) |
| % from All-Time High | -31.16% | -28.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.06% |
| Quarterly Earnings Growth | 0.13% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.22% | 0.15% |
| Operating Margin (TTM) | 0.31% | 0.18% |
| Return on Equity (TTM) | -36.77% | 0.14% |
| Debt to Equity (MRQ) | -95.84 | 82.91 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-1.16 | $141.96 |
| Cash per Share (MRQ) | $3.29 | $8.75 |
| Operating Cash Flow (TTM) | $955.77M | $8.29B |
| Levered Free Cash Flow (TTM) | $687.08M | $5.51B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.38% |
| Last 12-Month Dividend | N/A | $1.76 |
Valuation & Enterprise Metrics Analysis: Mettler-Toledo International Inc. vs Thermo Fisher Scientific Inc.
| Metric | MTD (Apr 24, 2026) | TMO (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.07 | 25.84 |
| Forward P/E | 24.70 | 17.16 |
| PEG Ratio | 1.79 | 2.29 |
| Price to Sales (TTM) | 6.36 | 3.86 |
| Price to Book (MRQ) | -1,090.80 | 3.31 |
| Market Capitalization | ||
| Market Capitalization | $25.60B | $174.55B |
| Enterprise Value | $27.90B | $214.76B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.93 | 4.75 |
| Enterprise to EBITDA | 23.02 | 19.02 |
| Risk & Other Metrics | ||
| Beta | 1.44 | 0.97 |
| Book Value per Share (MRQ) | $-1.16 | $141.96 |
Financial Statements Comparison: Mettler-Toledo International Inc. vs Thermo Fisher Scientific Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MTD (2025) | TMO (2025) |
|---|---|---|
| Revenue/Sales | 4.03B | 44.56B |
| Cost of Goods Sold | 1.64B | 26.32B |
| COGS % of Revenue | 40.6% | 59.1% |
| Gross Profit | 2.39B | 18.24B |
| Gross Margin | 59.4% | 40.9% |
| Research & Development | 199.37M | 1.40B |
| Operating Income (EBIT) | 1.12B | 8.11B |
| Operating Margin | 27.8% | 18.2% |
| EBITDA | 1.26B | 11.86B |
| EBITDA Margin | 31.3% | 26.6% |
| Pre-Tax Income | 1.05B | 7.31B |
| Pre-Tax Income % of Revenue | 26.1% | 16.4% |
| Income Tax | 179.72M | 547.00M |
| Income Tax % of Revenue | 4.5% | 1.2% |
| Net Income (Profit) | 869.19M | 6.72B |
| Profit Margin | 21.6% | 15.1% |
Balance Sheet & Liquidity Metrics
| Metric | MTD (2025) | TMO (2025) |
|---|---|---|
| Cash & Equivalents | 66.89M | 9.85B |
| Total Current Assets | 1.36B | 28.71B |
| Total Current Assets % of Revenue | 33.8% | 64.4% |
| Total Current Liabilities | 1.20B | 15.19B |
| Total Current Liabilities % of Revenue | 29.8% | 34.1% |
| Long-Term Debt | 2.09B | 35.85B |
| Long-Term Debt % of Revenue | 51.9% | 80.5% |
| Total Shareholders Equity | -23.64M | 53.54B |
| Retained Earnings | 9.24B | 59.16B |
| Retained Earnings % of Revenue | 229.4% | 132.8% |
| Property, Plant & Equipment | 0 | 0 |
Cash Flow Statement Comparison
| Metric | MTD (2025) | TMO (2025) |
|---|---|---|
| Operating Cash Flow | 990.02M | 7.82B |
| Operating Cash Flow % of Revenue | 24.6% | 17.5% |
| Capital Expenditures | -107.12M | -1.48B |
| Free Cash Flow | 848.65M | 6.29B |
| FCF Margin | 21.1% | 14.1% |
| Debt Repayment | -1.97B | -3.51B |
| Common Stock Repurchase | -800.00M | -3.00B |
Short Interest & Institutional Ownership Analysis
| Metric | MTD | TMO |
|---|---|---|
| Shares Short | 607,385 | 4.54M |
| Short Ratio | 3.29 | 2.38 |
| Short % of Float | 3.44% | 1.22% |
| Shares Outstanding | 20.36M | 371.62M |
| Float Shares | 20.22M | 371.07M |
| % Held by Insiders | 0.43% | 0.17% |
| % Held by Institutions | 102.91% | 95.23% |
| % Held by Public | -3.34% | 4.60% |
Dividend Analysis & Yield Comparison: Mettler-Toledo International Inc. vs Thermo Fisher Scientific Inc.
| Metric | MTD | TMO |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.76 |
| Last 12-Month Dividend Yield | N/A | 0.38% |
| 3-Year Avg Annual Dividend | N/A | $1.60 |
| 3-Year Avg Dividend Yield | N/A | 0.08% |
| 3-Year Total Dividends | N/A | $4.80 |
| Ex-Dividend Date | N/A | Mar 13, 2026 |